Kopra Bio
Genetically engineered viruses that teach your immune system to kill…
San Francisco, United States · Founded 2024 · $600K raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2024
- Website
- kopra.bio
- Total Funding
- $600K
- Last Round
- $100K GrantJan 2025
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.
About
Kopra Bio makes genetically engineered viruses that teach your immune system to kill cancer using tech we developed at UCSF. We’re making the next Keytruda ($25B/yr cancer drug blockbuster) starting with the most aggressive form of brain cancer, glioblastoma. In the most challenging brain cancer model, we improve survival from 0% with the current FDA approved treatment to 90% with our treatment.
Summary
Kopra Bio is a Biotech company based in San Francisco, United States, founded in 2024. It has raised $600K in total across 2 rounds, most recently a $100K Grant round in Jan 2025. Investors include QB3, Y Combinator and Pioneer Fund.
Funding History
Jan 2025
Sign up to see all 2 events
Funding: Seed through Grant. Amounts, valuations, and investors where available.
Investors
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/kopra-bio"><img src="https://indexed.vc/api/badge/company/kopra-bio" alt="Kopra Bio on Indexed.vc" width="260" height="76" /></a>